Regulations.gov document
Letter from King & Spalding on behalf of Givaudan-Roure Corporation to FDA CDER
Other · FDA-1978-N-0018 · posted Apr 3, 2018
Key facts
| Document ID | FDA-1978-N-0018-0822 |
|---|---|
| Title | Letter from King & Spalding on behalf of Givaudan-Roure Corporation to FDA CDER |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-1978-N-0018 |
| Posted | Apr 3, 2018 |
| Comment period opens | Apr 3, 2018 |
| Effective date | Sep 24, 1993 |
At a glance
- 1,000+ Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: